Cargando…
Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry
INTRODUCTION: Cannabis-based medicinal products (CBMPs) have been identified as a promising novel therapeutic for symptoms and comorbidities related to autism spectrum disorder (ASD). However, there is a paucity of clinical evidence of their efficacy and safety. Objective: This case series aims to a...
Autores principales: | Erridge, Simon, Kerr-Gaffney, Jess, Holvey, Carl, Coomber, Ross, Barros, Daniela A. Riano, Bhoskar, Urmila, Mwimba, Gracia, Praveen, Kavita, Symeon, Chris, Sachdeva-Mohan, Simmi, Sodergren, Mikael H., Rucker, James J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500308/ https://www.ncbi.nlm.nih.gov/pubmed/36159065 http://dx.doi.org/10.1177/20451253221116240 |
Ejemplares similares
-
Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry
por: Rifkin-Zybutz, Raphael, et al.
Publicado: (2023) -
Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis‐Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry
por: Kawka, Michal, et al.
Publicado: (2021) -
Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy—Analysis from the UK Medical Cannabis Registry
por: Erridge, Simon, et al.
Publicado: (2023) -
Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK Medical Cannabis Registry
por: Wang, Claire, et al.
Publicado: (2023) -
An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patients
por: Erridge, Simon, et al.
Publicado: (2021)